Document is current

Any future updates will be listed below

Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy

Crossref DOI link: https://doi.org/10.1186/s13148-015-0065-5

Published Online: 2015-03-17

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark